Back to search

United Kingdom· GB-APID-41330911000001105

Rapibloc 300mg powder for solution for infusion vials

A landiolol product containing landiolol, registered in United Kingdom by AOP Orphan Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC C07AB14

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRapibloc 300mg powder for solution fo…ATCC07AB14REGISTER NO.GB-APID-4133091100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Landiolol is registered in 15 of 19 countries.

Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Landiolol · ATC C07AB14

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Landiolol
Manufacturer
AOP Orphan Ltd
Country
United Kingdom (GB)
ATC code
C07AB14
ATC class
Landiolol
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    9120093140528
  • gtin
    09120093140528

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Landiolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All landiolol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Rapibloc
  • Belgium · Runrapiq
  • Bulgaria · Рапиблок
  • Cyprus · Rapibloc
  • Czechia · Rapibloc
  • Germany · Rapibloc
  • Denmark · Rapibloc
  • Estonia · Raploc
  • Spain · Rapibloc
  • Finland · Rapibloc
  • France · Rapibloc
  • Greece · Rapibloc
  • Croatia · Rapibloc
  • Hungary · Rapibloc
  • Ireland · Rapibloc
  • Italy · Landiobloc
  • Lithuania · Raploc
  • Latvia · Raploc
  • Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
  • Norway · Raploc
  • Poland · Runrapiq
  • Portugal · Rapibloc
  • Romania · Rapibloc
  • Sweden · Rapibloc
  • Slovenia · Rapibloc
  • Slovakia · Rapibloc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55cb5818-a6f9-4db0-a733-eb949370b7ad
GET /v1/drugs/55cb5818-a6f9-4db0-a733-eb949370b7ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41330911000001105",
  "desc": "Rapibloc 300mg powder for solution for infusion vials (AOP Orphan Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "41391111000001105",
  "source": "dmd",
  "vtm_id": "41358211000001104",
  "strength": "300 mg",
  "substance": "Landiolol",
  "ingredient": "Landiolol hydrochloride",
  "supplier_code": "20353611000001102"
}

See everything about landiolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.